Background
HA-CDI
Hospital-acquired Use of systemic antibiotics is a common occurrence in hospital, and is a main risk factor for HA-CDI [The prescribing and timely administration of Bio-K + ® was important for the successful evaluation of the effectiveness of the probiotic for prevention of HA-CDI in the study population. As a result, the objective of this study was to identify potential barriers and facilitators to the successful implementation of the Prevent CDI-55 + study. We conducted focus groups and interviews throughout the Prevent CDI-55 + study to develop and adapt a multifactorial barrier- and facilitator-targeted strategy for the administration of Bio-K + ®.